Similarly, recent studies involving a small fraction of PTCL patients have described missense mutations in JAK1, JAK2, JAK3, STAT3, and STAT5B10–12. This evidence concerns the gene JAK3 and mature T-cell and NK-cell non-Hodgkin lymphoma.